Seattle, WA, United States of America

Arvia Eleanor Morris

This inventor holds 23 USPTO granted patents and 9 published patent applications, plus 2 CIPO patents and 7 EPO patents, primarily in Mammalian Cell Culture. Top assignees: Immunex Corporation, Amgen Inc.. Active years: 1999-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arvia Eleanor Morris. Retrieved from https://idiyas.com/inventor/arvia-eleanor-morris

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 

% Patents Active = 95.7

 

 

Average Co-Inventor Count = 3.0

ph-index = 6

Forward Citations = 246(Granted Patents)


Company Filing History:


Years Active: 1999-2023

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Mammalian Cell Culture
Recombinant Protein Production
Anti-Interleukin-4 Antibodies
Feed Media
Dipeptides
Eukaryotic Expression Systems
Translation Regulation
CD40 Ligand
Cytokines
Expression Augmenting Sequence Elements
Viability Enhancement
Host Cells
23 patents (USPTO):Explore Patents

Title: The Innovations of Arvia Eleanor Morris in Mammalian Cell Culture

Introduction: Arvia Eleanor Morris is a prominent inventor based in Seattle, WA, who has made significant contributions to the field of biotechnology. With a total of 23 patents to her name, Morris has focused her research on improving methods for culturing mammalian cells, thereby facilitating advancements in various biological applications.

Latest Patents: Among her notable patents, Morris has developed innovative techniques for mammalian cell culture. Her latest inventions provide a method that allows for greater control over cell growth, which leads to high product titer cell cultures. This advancement not only enhances production efficiency but also contributes to the overall effectiveness of biological research and therapeutic development.

Career Highlights: Throughout her career, Arvia Eleanor Morris has worked with renowned companies in the biotechnology sector, including Immunex Corporation and Amgen Inc. These positions have allowed her to apply her inventive insights to real-world challenges, furthering the advancement of biotechnological methods and applications.

Collaborations: Morris has collaborated with several talented professionals during her career, including Rebecca E. McCoy and Richard Jeffrey Armitage. Through these partnerships, they have explored innovative solutions and pushed the boundaries of research in cell culture techniques, significantly impacting the field.

Conclusion: Arvia Eleanor Morris exemplifies the spirit of innovation in biotechnology, with her extensive patent portfolio and impactful career. Her methods for mammalian cell culture represent a significant leap forward, enabling greater control and efficiency in biological research. As she continues her work, the contributions of Morris will undoubtedly influence future inventions and breakthroughs in the biotechnology sector.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…